Hussein El-Subbagh

Mansoura University, Egypt

Scopus profile: link
Researcher ID: F-4169-2010
GoogleScholar profile: link
ID ORCID: http://orcid.org/0000-0002-5891-9883

Selected Publications:

  1. Moharram, E. A., El-Sayed, S. M., Ghabbour, H. A., El-Subbagh, H. I. (2024). Synthesis, molecular modeling simulations and anticancer activity of some new Imidazo[2,1-b]thiazole analogues as EGFR/HER2 and DHFR inhibitors. Bioorganic Chemistry, 150, 107538. https://doi.org/10.1016/j.bioorg.2024.107538

  2. Waly, O. M., El-Sayed, S. M., Ghaly, M. A., El-Subbagh, H. I. (2023). Multi-targeted anti-Alzheimer’s agents: Synthesis, biological evaluation, and molecular modeling study of some pyrazolopyridine hybrids. European Journal of Medicinal Chemistry, 262, 115880. https://doi.org/10.1016/j.ejmech.2023.115880

  3. Abdelshaheed, M. M., El Subbagh, H. I., Tantawy, M. A., Attia, R. T., Youssef, K. M., Fawzy, I. M. (2023). Discovery of new pyridine heterocyclic hybrids; design, synthesis, dynamic simulations, and in vitro and in vivo breast cancer biological assays. RSC Advances, 13 (23), 15689–15703. https://doi.org/10.1039/d3ra02875e

  4. Elsayed, R. W., Bayoumi, S. M., El-Subbagh, H. I., El-Sayed, S. M. (2023). Hydrazinecarbonyl-thiazol-2-acetamides with pronounced apoptotic behavior: synthesis, in vitro/in vivo anti-proliferative activity and molecular modeling simulations. Bioorganic & Medicinal Chemistry Letters, 87, 129285. https://doi.org/10.1016/j.bmcl.2023.129285

  5. El‐Gazzar, Y. I., Ghaiad, H. R., El Kerdawy, A. M., George, R. F., Georgey, H. H., Youssef, K. M., El‐Subbagh, H. I. (2022). New quinazolinone‐based derivatives as DHFR/EGFR‐TK inhibitors: Synthesis, molecular modeling simulations, and anticancer activity. Archiv Der Pharmazie, 356 (1), 2200417. https://doi.org/10.1002/ardp.202200417

  6. Mansour, N.I., El-Sayed, S.M., El-Gohary, N.S., Abdel-Aziz, N. I., El-Subbagh, H.I., Ghaly, M.A. (2022). New phthalimide-based derivatives as EGFR-TK inhibitors: Synthesis, biological evaluation, and molecular modeling study. Bioorganic Chemistry, 127, 105966. https://doi.org/10.1016/j.bioorg.2022.105966 

  7. Mansour, N. M., El-Sherbiny, D. T., Ibrahim, F. A., El Subbagh, H. I. (2022). Validation of a specific Reversed-Phase HPLC method for the quantification of three racetams; Piracetam, Levetiracetam, and brivaracetam in the presence of Co-administered drugs in their pharmaceuticals; greenness assessment and application to biological fluid and in-vitro dissolution testing. Microchemical Journal, 181, 107703. https://doi.org/10.1016/j.microc.2022.107703